Clinical Lab 2.0 places labs at the forefront of better healthcare delivery, through an innovative new business model.

The world of healthcare is changing – the clinical laboratory is changing with it. While the traditional, transactional lab model continues to serve as a foundation, the emerging Clinical Lab 2.0 business model leverages longitudinal laboratory data to produce actionable, clinical insight, driving better outcomes for patients, providers, and financial stakeholders alike. Clinical Lab 2.0 re-engineers the role of lab in the care continuum, aligning with the future of value-based healthcare.

Clinical Lab 2.0 Workshop

The 4th Annual Clinical Lab 2.0 Workshop | October 26-27, 2020 | Virtual Event

SAVE THE DATE

Clinical Lab 2.0 appreciates the support provided

by our 2020 industry partners

Clinical Lab 2.0 is widely featured

Improving Global Healthcare Through Clinical Lab 2.0

Lab 2.0: Lab Leadership’s Link to Patient Outcomes

In this recorded webinar from the CDC Division of Laboratory Systems, James M. Crawford, M.D., Ph.D. discusses how the Clinical Laboratory is being recognized as necessary and foundational to patient care and public health, and is the key to getting the COVID-19 Pandemic in check.

Watch now

Meet the Leadership

View the Board of Directors

Khosrow R. Shotorbani, MBA, MT (ASCP)

Michael J. Crossey, MD, PhD

James Crawford, MD, PhD

Myra Wilkerson, MD

Richard Zarbo, MD, DMD

Mark Fung, MD, PhD

Curt Hanson, MD

Karen Kaul, MD, PhD

Sterling T. Bennett, MD, MS

Thomas S. Lorey, MD

More about the Clinical Lab 2.0 workshop

Interested in joining us at the 4th Annual Clinical Lab 2.0 Workshop?

Get in touch

Heard in the industry

“Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation”

Journal of Applied Laboratory Medicine

“An intriguing and stimulating chance to meet with thought leaders and interact with other executives facing the need to reorient their labs to a value-based perspective”